Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3426545rdf:typepubmed:Citationlld:pubmed
pubmed-article:3426545lifeskim:mentionsumls-concept:C1257740lld:lifeskim
pubmed-article:3426545lifeskim:mentionsumls-concept:C0597295lld:lifeskim
pubmed-article:3426545lifeskim:mentionsumls-concept:C0005919lld:lifeskim
pubmed-article:3426545lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:3426545lifeskim:mentionsumls-concept:C1519249lld:lifeskim
pubmed-article:3426545lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:3426545lifeskim:mentionsumls-concept:C1514873lld:lifeskim
pubmed-article:3426545lifeskim:mentionsumls-concept:C1707271lld:lifeskim
pubmed-article:3426545pubmed:issue2lld:pubmed
pubmed-article:3426545pubmed:dateCreated1988-1-27lld:pubmed
pubmed-article:3426545pubmed:abstractText1. Synthetic peptides corresponding to the five, seven, nine and eleven C-terminal amino acids of the tetradecapeptide bombesin as well as bombesin itself and gastrin-releasing peptide have been evaluated in Swiss 3T3 cells in order to define the minimal peptide length needed for biological responsiveness. 2. Gastrin-releasing peptide, bombesin, the undecapeptide and nonapeptide had nearly equipotent abilities to compete for binding of labelled gastrin-releasing peptide to the cell receptors and showed half-maximal competition at 5-10 nM. The heptapeptide and pentapeptide were ineffective. 3. Cross-linking experiments demonstrated specific binding of gastrin-releasing peptide to a 100 kDa receptor subunit. 4. Total cell protein synthesis was stimulated equally by the nonapeptide and longer peptides with a half-maximal effect at 0.5 nM, while a more than 1000-fold higher concentration of the heptapeptide was required to produce a similar response. Comparable results were found when insulin was also present. 5. Neither an inhibition of protein breakdown nor a stimulation of DNA labelling could be demonstrated by bombesin or gastrin-releasing peptide. 6. We conclude that a C-terminal peptide ligand comprising more than seven but no more than nine amino acids is required to achieve high-affinity binding and receptor-mediated responses via the bombesin receptor.lld:pubmed
pubmed-article:3426545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3426545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3426545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3426545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3426545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3426545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3426545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3426545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3426545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3426545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3426545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3426545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3426545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3426545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3426545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3426545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3426545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3426545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3426545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3426545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3426545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3426545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3426545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3426545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3426545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3426545pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3426545pubmed:languageenglld:pubmed
pubmed-article:3426545pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3426545pubmed:citationSubsetIMlld:pubmed
pubmed-article:3426545pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3426545pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3426545pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3426545pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3426545pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3426545pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3426545pubmed:statusMEDLINElld:pubmed
pubmed-article:3426545pubmed:monthOctlld:pubmed
pubmed-article:3426545pubmed:issn0264-6021lld:pubmed
pubmed-article:3426545pubmed:authorpubmed-author:BallardF JFJlld:pubmed
pubmed-article:3426545pubmed:authorpubmed-author:WallaceJ CJClld:pubmed
pubmed-article:3426545pubmed:authorpubmed-author:GargoskyS ESElld:pubmed
pubmed-article:3426545pubmed:authorpubmed-author:UptonF MFMlld:pubmed
pubmed-article:3426545pubmed:issnTypePrintlld:pubmed
pubmed-article:3426545pubmed:day15lld:pubmed
pubmed-article:3426545pubmed:volume247lld:pubmed
pubmed-article:3426545pubmed:ownerNLMlld:pubmed
pubmed-article:3426545pubmed:authorsCompleteYlld:pubmed
pubmed-article:3426545pubmed:pagination427-32lld:pubmed
pubmed-article:3426545pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:3426545pubmed:meshHeadingpubmed-meshheading:3426545-...lld:pubmed
pubmed-article:3426545pubmed:meshHeadingpubmed-meshheading:3426545-...lld:pubmed
pubmed-article:3426545pubmed:meshHeadingpubmed-meshheading:3426545-...lld:pubmed
pubmed-article:3426545pubmed:meshHeadingpubmed-meshheading:3426545-...lld:pubmed
pubmed-article:3426545pubmed:meshHeadingpubmed-meshheading:3426545-...lld:pubmed
pubmed-article:3426545pubmed:meshHeadingpubmed-meshheading:3426545-...lld:pubmed
pubmed-article:3426545pubmed:meshHeadingpubmed-meshheading:3426545-...lld:pubmed
pubmed-article:3426545pubmed:meshHeadingpubmed-meshheading:3426545-...lld:pubmed
pubmed-article:3426545pubmed:meshHeadingpubmed-meshheading:3426545-...lld:pubmed
pubmed-article:3426545pubmed:meshHeadingpubmed-meshheading:3426545-...lld:pubmed
pubmed-article:3426545pubmed:meshHeadingpubmed-meshheading:3426545-...lld:pubmed
pubmed-article:3426545pubmed:meshHeadingpubmed-meshheading:3426545-...lld:pubmed
pubmed-article:3426545pubmed:year1987lld:pubmed
pubmed-article:3426545pubmed:articleTitleC-terminal bombesin sequence requirements for binding and effects on protein synthesis in Swiss 3T3 cells.lld:pubmed
pubmed-article:3426545pubmed:affiliationDepartment of Biochemistry, University of Adelaide, South Australia.lld:pubmed
pubmed-article:3426545pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3426545pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3426545lld:pubmed